• 1. Evolution of shape, size, and areal density of a single plane of Si nanocrystals embedded in SiO2 matrix studied by atom probe tomography
  Bin Han,Yasuo Shimizu,Gabriele Seguini,Celia Castro,Gérard Ben Assayag,Koji Inoue,Yasuyoshi Nagai,Sylvie Schamm-Chardon,Michele Perego RSC Adv., 2016,6, 3617-3622
• 2. Excellent lithium ion storage property of porous MnCo2O4 nanorods?
  Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084
• 3. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788
• 4. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696
• 5. Enabling non-flammable Li-metal batteries via electrolyte functionalization and interface engineering?
  Jing Yu,Yu-Qi Lyu,Jiapeng Liu,Mohammed B. Effat,Junxiong Wu J. Mater. Chem. A, 2019,7, 17995-18002

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acid esters
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids and derivatives Benzoic acid esters

Methyl 2-cyano-5-methylbenzoate (CAS No. 127510-94-5): A Comprehensive Overview in Modern Chemical Research

Methyl 2-cyano-5-methylbenzoate, identified by its chemical abstracts service number CAS No. 127510-94-5, is a significant compound in the realm of organic chemistry and pharmaceutical research. This compound, featuring a benzoate ester group and a cyano substituent, has garnered attention due to its versatile applications in synthetic chemistry and potential roles in drug development. The structural uniqueness of Methyl 2-cyano-5-methylbenzoate makes it a valuable intermediate in the synthesis of more complex molecules, particularly in the field of medicinal chemistry.

The benzoate moiety in Methyl 2-cyano-5-methylbenzoate contributes to its stability and reactivity, making it a preferred choice for various chemical transformations. Recent studies have highlighted its utility in the synthesis of nonsteroidal anti-inflammatory drugs (NSAIDs) and other therapeutic agents. The cyano group, on the other hand, introduces a site for further functionalization, enabling the creation of derivatives with enhanced pharmacological properties.

In the context of modern pharmaceutical research, Methyl 2-cyano-5-methylbenzoate has been explored for its potential in developing novel treatments for neurological disorders. The compound's ability to interact with specific biological targets has been investigated through computational modeling and experimental validation. These studies suggest that derivatives of Methyl 2-cyano-5-methylbenzoate could serve as leads for new therapeutic strategies.

The synthesis of Methyl 2-cyano-5-methylbenzoate typically involves multi-step organic reactions, including esterification and cyanation processes. Advanced synthetic methodologies have been employed to optimize yield and purity, ensuring that the compound meets the stringent requirements of pharmaceutical applications. Techniques such as catalytic hydrogenation and palladium-catalyzed cross-coupling reactions have been particularly effective in achieving high-quality yields.

Recent advancements in green chemistry have also influenced the production of Methyl 2-cyano-5-methylbenzoate. Researchers are increasingly focusing on sustainable synthetic routes that minimize waste and reduce environmental impact. For instance, solvent-free reactions and microwave-assisted synthesis have been explored as alternative methods to conventional approaches, aligning with global efforts to promote eco-friendly chemical processes.

The pharmacological profile of Methyl 2-cyano-5-methylbenzoate has been a subject of extensive investigation. Preclinical studies have demonstrated its potential as an anticonvulsant and anxiolytic agent. The compound's interaction with neurotransmitter systems has been studied using both in vitro and in vivo models. These findings provide a foundation for further clinical trials aimed at evaluating its therapeutic efficacy in human populations.

In addition to its pharmaceutical applications, Methyl 2-cyano-5-methylbenzoate holds promise in materials science. Its unique structural features make it suitable for use as a precursor in the synthesis of advanced polymers and coatings. These materials exhibit enhanced durability and chemical resistance, making them valuable in industrial applications ranging from aerospace to automotive sectors.

The future direction of research on Methyl 2-cyano-5-methylbenzoate is likely to focus on expanding its therapeutic applications and exploring novel synthetic pathways. Collaborative efforts between academia and industry are expected to drive innovation, leading to the development of new derivatives with improved pharmacokinetic properties. Furthermore, interdisciplinary approaches combining chemistry, biology, and computer science will be instrumental in uncovering the full potential of this versatile compound.

• 500024-27-1(Methyl 2-cyano-3-methylbenzoate)
• 6587-24-2(Methyl 2-cyanobenzoate)
• 64754-35-4(1,2-BENZENEDICARBOXYLIC ACID, 4,5-DICYANO-, DIMETHYL ESTER)
• 58331-99-0(Methyl 2,4-dicyanobenzoate)
• 103856-64-0(1,2-Benzenedicarboxylic acid, 3-cyano-, dimethyl ester)
• 714237-94-2(Methyl 2,5-dicyanobenzoate)
• 93340-09-1(Methyl 3-cyano-2-methylbenzoate)
• 412031-32-4(1,3-Benzenedicarboxylic acid, 4-cyano-, dimethyl ester)
• 41573-40-4(1,4-Benzenedicarboxylic acid, 2,5-dicyano-, dimethyl ester)
• 1213767-07-7(Methyl 2-cyano-4-Methylbenzoate)